BE1002115A3 - Intermediaires et procedes pour la preparation de tetrazoles antihypercholesterolemiques. - Google Patents

Intermediaires et procedes pour la preparation de tetrazoles antihypercholesterolemiques. Download PDF

Info

Publication number
BE1002115A3
BE1002115A3 BE8800219A BE8800219A BE1002115A3 BE 1002115 A3 BE1002115 A3 BE 1002115A3 BE 8800219 A BE8800219 A BE 8800219A BE 8800219 A BE8800219 A BE 8800219A BE 1002115 A3 BE1002115 A3 BE 1002115A3
Authority
BE
Belgium
Prior art keywords
tetrazoles
preparation
antihypercholesterolemic
intermediates
processes
Prior art date
Application number
BE8800219A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of BE1002115A3 publication Critical patent/BE1002115A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Nouveaux tétrazoles intermédiaires de formule [cfr. fig.] où les différents substituants sont tels que le composé puisse être, par exemple le 1,1-bis-(4-fluorophényl)-2-(1-méthyl-1H-tétrazol-5-yl)-1-propène, le 3,3-bis-(4-fluorophényl)-1-bromo-2-(méthyl-1H-tétrazol-5-yl)-2-propène ou le 1,1-bis-(4-fluorophényl)-2-(1-méthyl-1H-tétrazol-5-yl)éthène qui sont utiles pour la préparation d'agents antihypercholestérolémiques, et procédés pour les préparer.
BE8800219A 1987-02-25 1988-02-25 Intermediaires et procedes pour la preparation de tetrazoles antihypercholesterolemiques. BE1002115A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1855887A 1987-02-25 1987-02-25
US07/151,512 US4898949A (en) 1987-02-25 1988-02-18 Intermediates for the preparation of antihypercholesterolemic tetrazole compounds

Publications (1)

Publication Number Publication Date
BE1002115A3 true BE1002115A3 (fr) 1990-07-10

Family

ID=26691250

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8800219A BE1002115A3 (fr) 1987-02-25 1988-02-25 Intermediaires et procedes pour la preparation de tetrazoles antihypercholesterolemiques.

Country Status (27)

Country Link
US (1) US4898949A (fr)
JP (1) JP2603284B2 (fr)
KR (1) KR960007167B1 (fr)
CN (1) CN1030077C (fr)
AT (1) AT395588B (fr)
AU (1) AU610562B2 (fr)
BE (1) BE1002115A3 (fr)
CA (1) CA1328269C (fr)
CH (1) CH678182A5 (fr)
DE (1) DE3805789C2 (fr)
DK (2) DK97388A (fr)
ES (1) ES2009547A6 (fr)
FI (1) FI96600C (fr)
FR (1) FR2611201B1 (fr)
GB (1) GB2202845B (fr)
GR (1) GR1000473B (fr)
HU (3) HU201534B (fr)
IE (1) IE61608B1 (fr)
IT (1) IT1216752B (fr)
LU (1) LU87143A1 (fr)
MY (1) MY102290A (fr)
NL (1) NL8800468A (fr)
NO (1) NO178432C (fr)
NZ (1) NZ223621A (fr)
PT (1) PT86821B (fr)
SE (3) SE504553C2 (fr)
YU (1) YU46781B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5260325A (en) * 1991-08-19 1993-11-09 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking tertiary amides
CA2137049A1 (fr) * 1993-12-15 1995-06-16 John K. Thottathil Sels d'acides amines de composes antihypercholesterolemiques a base de tetrazole et leur methode de preparation
KR100681366B1 (ko) * 1997-12-19 2007-02-12 워너-램버트 익스포트 리미티드 1,3-디올의 합성방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
NZ194557A (en) * 1979-08-17 1984-09-28 Merck & Co Inc Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
EP0068038B1 (fr) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4R.6S)-(E)-6-(2-(4'-fluoro-3,3',5-triméthyl-(1,1'-biphényl)-2-yle)éthenyl)-3,4,5,6-tétrahydro-4-hydroxy-2H-pyran-2-one, un procédé pour sa fabrication et une composition pharmaceutique la contenant
AU570021B2 (en) * 1982-11-22 1988-03-03 Novartis Ag Analogs of mevalolactone
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
PT77996B (en) * 1983-01-24 1986-05-30 Sandoz Sa Process of the preparations of mevalonelactone analogs and derivatives thereof and of pharmaceutical compositions containing them
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
CA1327360C (fr) * 1983-11-14 1994-03-01 William F. Hoffman Analogues oxo d'agents antihypercholesterolemiants ayant les caracteristiques de la mevinoline
JPS61502467A (ja) * 1984-06-22 1986-10-30 サンド・アクチエンゲゼルシヤフト メバロノラクトンのピラゾ−ル同族体およびその誘導体、それらの製造方法ならびに用途
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
AU601264B2 (en) * 1987-02-25 1990-09-06 Bristol-Myers Squibb Company Antihypercholesterolemic tetrazole compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses

Also Published As

Publication number Publication date
AU1213288A (en) 1988-09-01
FI96600B (fi) 1996-04-15
DK97388D0 (da) 1988-02-24
ES2009547A6 (es) 1989-10-01
SE503201C2 (sv) 1996-04-15
IT8819526A0 (it) 1988-02-24
LU87143A1 (fr) 1988-09-20
JPS63290872A (ja) 1988-11-28
FR2611201A1 (fr) 1988-08-26
GB8804281D0 (en) 1988-03-23
FI880868A0 (fi) 1988-02-24
NZ223621A (en) 1991-06-25
ATA46088A (de) 1992-06-15
AT395588B (de) 1993-01-25
DE3805789C2 (de) 2001-05-31
CN1030077C (zh) 1995-10-18
MY102290A (en) 1992-05-15
GR880100100A (en) 1988-12-16
GB2202845B (en) 1991-05-22
SE9300977L (fr)
PT86821B (pt) 1992-05-29
IT1216752B (it) 1990-03-08
YU36488A (en) 1990-02-28
PT86821A (pt) 1988-03-01
HU201532B (en) 1990-11-28
GB2202845A (en) 1988-10-05
JP2603284B2 (ja) 1997-04-23
NO178432B (no) 1995-12-18
SE512485C2 (sv) 2000-03-20
CA1328269C (fr) 1994-04-05
NO880802D0 (no) 1988-02-24
GR1000473B (el) 1992-07-30
FI880868A (fi) 1988-08-26
IE880502L (en) 1988-08-18
HU201533B (en) 1990-11-28
KR960007167B1 (ko) 1996-05-29
YU46781B (sh) 1994-05-10
IE61608B1 (en) 1994-11-16
KR880009946A (ko) 1988-10-06
DK97388A (da) 1988-08-26
FR2611201B1 (fr) 1991-01-11
FI96600C (fi) 1996-07-25
HUT47258A (en) 1989-02-28
AU610562B2 (en) 1991-05-23
SE8800637L (sv) 1988-08-26
NO880802L (no) 1988-08-26
SE9300976D0 (sv) 1993-03-24
NO178432C (no) 1996-03-27
CH678182A5 (fr) 1991-08-15
DE3805789A1 (de) 1988-09-15
SE9300977D0 (sv) 1993-03-24
SE9300976L (fr) 1993-03-24
SE504553C2 (sv) 1997-03-03
US4898949A (en) 1990-02-06
SE8800637D0 (sv) 1988-02-24
NL8800468A (nl) 1988-09-16
HU201534B (en) 1990-11-28
CN1070642A (zh) 1993-04-07
HU895124D0 (fr) 1990-01-28
DK113897A (da) 1997-10-06

Similar Documents

Publication Publication Date Title
FR2428632A1 (fr) Derives d'imidazole pour le traitement des thromboses
KR830009050A (ko) 항종양 퀴나졸린 화합물의 제조방법
CA2203618A1 (fr) Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BE1002116A3 (fr) Tetrazoles antihypercholesterolemiques.
FI902555A0 (fi) Diarylstyrylkinolindisyror.
EP0318084A3 (fr) Benzohétérazoles
FR2371434A1 (fr) Derives triazoliques utiles comme fongicides
FR2419261A1 (fr) Procede de production de liants durcissants a base de ciment
FR2392013A1 (fr) Ethers d'azolyl-acetophenonoxime utiles comme fongicides
BE1002115A3 (fr) Intermediaires et procedes pour la preparation de tetrazoles antihypercholesterolemiques.
ES2008962A6 (es) Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol
FR2434572A1 (fr) Derives d'oximes pour la protection des cultures
EP0304966A3 (fr) Bêta-cétonitriles
FR2358237A1 (fr) Composition fluide dielectrique pour travailler un metal par un procede d'electro-erosion
FR2368473A1 (fr) O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs
FI863813A0 (fi) Pesticida foereningar.
EP0182603A3 (fr) Dérivés alcanesulfonate utiles comme insecticide, acaricide et nématicide
KR830009085A (ko) (피리딘일)-y-벤즈이미다졸
GB1417322A (en) Acylamines of bicyclic hydrocarbons for the regulation of plant growth
FR2442236A1 (fr)
FR2430426A1 (fr) Derives d'acides biliaires marques, utilisables pour le diagnostic medical
EP0250115A3 (fr) Dérivés de 2,5-pyrrolidinediones obtenus à partir de bactérie et leur utilisation comme bactéricide
BE898834A (fr) Procede pour la preparation d'oxime ethers basiques
FI853907L (fi) Mellanprodukter foer framstaellning av 16-fenoxi- och 16-substituerade fenoxi-prostatriensyraderivat.
NO903514D0 (no) Imidazolderivat og fremgangsmaate til dets fremstilling.

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20050228

RE Patent lapsed

Effective date: 20050228